top of page

CMC and margins make cell and gene therapy a different kind of medicine

Dark Horse Consulting's Anthony Davies discusses CMC issues to consider when developing cell and gene therapies.



留言


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page